(Q40981495)

25 September 2017

Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity (English)

1 reference

25 September 2017

1 reference

6

P J Bingley

1 reference

25 September 2017

E Bonifacio

1

1 reference

25 September 2017

S Genovese

2

1 reference

25 September 2017

S Braghi

3

1 reference

25 September 2017

E Bazzigaluppi

4

1 reference

25 September 2017

V Lampasona

5

1 reference

25 September 2017

L Rogge

7

1 reference

25 September 2017

M R Pastore

8

1 reference

25 September 2017

E Bognetti

9

1 reference

25 September 2017

G F Bottazzo

10

1 reference

25 September 2017

1 July 1995

1 reference

25 September 2017

1 reference

25 September 2017

38

1 reference

25 September 2017

816-822

1 reference

25 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s001250050358

25 September 2017

0 references

cites work

Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Autoantibodies in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Quantitation of mRNA by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

Can we really predict IDDM?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050358

A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes

21 January 2018

1 reference

12 December 2020

Natural history of preclinical IDDM in high risk siblings. Childhood Diabetes in Finland Study Group

1 reference

12 December 2020

Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type I diabetic children

1 reference

12 December 2020

Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes

1 reference

12 December 2020

Progress toward standardization of cytoplasmic islet cell-antibody assay

1 reference

12 December 2020

A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM

1 reference

12 December 2020

Combined analysis of IDDM-related autoantibodies in healthy schoolchildren

1 reference

12 December 2020

Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay

1 reference

12 December 2020

Islet cell antibody heterogeneity among type 1 (insulin-dependent) diabetic patients

1 reference

12 December 2020

Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives

1 reference

12 December 2020

Identifiers

DOI

10.1007/S001250050358

1 reference

25 September 2017

1 reference